Al3818: Clinical Trials

1 trial of Al3818, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Al3818: new trials by email Literature Review of Al3818 trials Research Report on Al3818

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line(ALTER-L020)
Anlotinib - Non-squamous NSCLC
Phase 4UnknownFirst Affiliated Hospital Xi'an Jiaotong University1032018-11-292020-04-03

Sponsors

First Affiliated Hospital Xi'an Jiaotong University (1)

Countries

China (1)